Potential Role of Hydroxyapatite Nanocrystalline for Early Diagnostics of Ovarian Cancer.

calcification early diagnostics hydroxyapatite ovarian cancer

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
22 Sep 2021
Historique:
received: 12 08 2021
revised: 08 09 2021
accepted: 16 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

Calcification is one of the clinical and morphological manifestations of ovarian tumors and it begins at the initial stages of carcinogenesis. Thus, this process can be used for the early diagnostics of some malignant ovarian tumors. We compared the results of ultrasound and histology and found that calcifications of a size less than 200 μm are not detected by ultrasound. These calcified structures are round fragile particles of different sizes. In the EDX (Energy-dispersive X-ray spectroscopy) spectra, the main lines were from Ca and P, and the ratio of these elements corresponds to hydroxyapatite. Thus, we established that hydroxyapatite is the main mineral component of ovarian psammoma bodies and could be used for early diagnostics of ovarian malignant neoplasia.

Identifiants

pubmed: 34679439
pii: diagnostics11101741
doi: 10.3390/diagnostics11101741
pmc: PMC8534774
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Education and Science of Ukraine
ID : No. 0112U100471

Références

Georgian Med News. 2013 Jan;(214):54-61
pubmed: 23388536
Nanomedicine (Lond). 2014 Mar;9(3):397-412
pubmed: 23614636
Clin Calcium. 2014 Feb;24(2):185-9
pubmed: 24473351
Calcif Tissue Int. 2013 Oct;93(4):348-54
pubmed: 23334303
Abdom Radiol (NY). 2016 Aug;41(8):1589-95
pubmed: 26969496
Br J Radiol. 2009 Aug;82(980):640-4
pubmed: 19332521
J Biomed Res. 2010 Jul;24(4):257-63
pubmed: 23554638
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Int J Mol Sci. 2020 Dec 24;22(1):
pubmed: 33374380
Mod Pathol. 2003 Mar;16(3):219-22
pubmed: 12640101
Pathol Int. 2000 Jul;50(7):531-5
pubmed: 10886734
Ultrasound Obstet Gynecol. 2007 Apr;29(4):438-42
pubmed: 17274104
Int J Womens Health. 2019 Apr 30;11:287-299
pubmed: 31118829
Diagn Cytopathol. 2009 Jul;37(7):534-41
pubmed: 19373908
J Nippon Med Sch. 2005 Feb;72(1):29-33
pubmed: 15834205
Adv Anat Pathol. 2019 Sep;26(5):329-339
pubmed: 31368906
J Cancer. 2018 Feb 28;9(6):1006-1016
pubmed: 29581780
Int J Mol Sci. 2019 Feb 22;20(4):
pubmed: 30813239
J Atheroscler Thromb. 2018 Apr 1;25(4):294-303
pubmed: 29238011
Diagnostics (Basel). 2017 Mar 02;7(1):
pubmed: 28257098

Auteurs

Ruslana Chyzhma (R)

Department of Pathology, Sumy State University, 40007 Sumy, Ukraine.

Artem Piddubnyi (A)

Department of Pathology, Sumy State University, 40007 Sumy, Ukraine.
Ukrainian-Swedish Research Center SUMEYA, Sumy State University, 40022 Sumy, Ukraine.
Department of Medical Biochemistry and Biophysics, Umea University, SE-90736 Umea, Sweden.

Sergey Danilchenko (S)

Institute of Applied Physics NAS of Ukraine, 40007 Sumy, Ukraine.

Olha Kravtsova (O)

Department of Pathology, Sumy State University, 40007 Sumy, Ukraine.
Pathology Department, Sumy Regional Oncological Hospital, 40022 Sumy, Ukraine.

Roman Moskalenko (R)

Department of Pathology, Sumy State University, 40007 Sumy, Ukraine.
Ukrainian-Swedish Research Center SUMEYA, Sumy State University, 40022 Sumy, Ukraine.

Classifications MeSH